MEMPHIS, Tenn., Sept. 11, 2025 /PRNewswire/ — uLab Systems®, a leader in digital orthodontic innovation, and Biolux Technology, creator of the OrthoPulse® near-infrared (NIR) light therapy device, announce a strategic partnership that bundles uSmile™ aligners with the OrthoPulse device as an option on the uDesign® Cloud platform. This landmark alliance brings together two disruptive technologies to create a new gold standard in clear aligner therapy.
A First-of-Its-Kind Integration: Biological Acceleration Meets Digital Precision
This collaboration combines OrthoPulse’s clinically validated light therapy—designed to stimulate bone remodeling and accelerate tooth movement—with uLab’s advanced clear aligner platform, known for its AI-assisted planning and flexible options for uSmile aligners.
The result:
- Up to 50% faster treatment times
- Fewer refinements and mid-course corrections
- Significantly reduced patient discomfort
- Elevated confidence for doctors with more predictable outcomes
- Boosted patient compliance with the OrthoPulse App, which tracks progress and sends reminders.
“This partnership is about more than combining technologies—it’s about redefining what’s possible in orthodontics,” said Michael Hendricks at Biolux Technology. “Together, we’re giving orthodontists the tools to deliver more personalized, efficient, and comfortable care—without compromise.”
Transforming the Patient Experience—from Start to Smile
This bundled offering, available early September through uLab providers, allows orthodontists to deliver a smarter, more streamlined treatment journey. Patients will benefit from both advanced uSmile aligners with Reva material and a biologically enhanced, digitally optimized process that gets them to their ideal smile faster, and with greater comfort. uLab customers will simply choose the combined bundle at checkout to have both the uSmile aligners and the OrthoPulse device simultaneously ship to the practitioner’s office.
“The combination of OrthoPulse and uLab represents a paradigm shift in how we think about clear aligner therapy,” added Gary Les, CEO of uLab Systems. “We’re aligning biological science with AI-driven treatment planning and advanced aligner material technology—bringing precision, speed, and comfort into harmony.”
A Bold Step Toward the Future of Orthodontics
As the demand for efficient, patient-friendly orthodontic care continues to grow, this partnership underscores Biolux and uLab’s shared commitment to innovation, clinical excellence, and transformative patient outcomes. By bridging biological stimulation with intelligent treatment planning, they are not just enhancing the aligner experience—they are setting a new benchmark for the entire industry.
About uLab Systems
uLab’s mission is to advance the orthodontic industry with aligner products and digital treatment planning software that lets orthodontists take back control of their treatment plans to provide the best outcomes for their patients. uLab sustainably manufactures uSmile aligners in Memphis, Tennessee, recycling over 80% of manufacturing mold materials. uSmile clear aligners, the uAssist concierge service, and the uDesign software are available to orthodontic practices in the USA. To learn more, visit www.ulabsystems.com.
Contact: Johanna Beckmen, VP of Marketing & Commercial Operations, [email protected].
About Biolux Technology
Biolux Technology is a global leader in light-accelerated orthodontics, dedicated to advancing clinical outcomes and patient experience through science-backed innovation. Its flagship product, OrthoPulse®, leverages near-infrared light to safely and effectively stimulate bone remodeling and accelerate tooth movement. To learn more, visit www.orthopulse.com.
Contact: Mike Hendricks, Chief Business Officer, [email protected].
© 2025 uLab Systems, Inc. All Rights Reserved. uSmile is a trademark and uLab, uLab Systems, uDesign, uAssist, and Reva are registered trademarks of uLab Systems, Inc. All other trademarks are the property of their respective owners. MAR-0001948 Rev 1
SOURCE uLab Systems, Inc.